{"gene":"CPM","run_date":"2026-04-28T17:28:53","timeline":{"discoveries":[{"year":1989,"finding":"Human carboxypeptidase M (CPM) was purified to homogeneity from placental microvilli and characterized as a membrane-bound zinc-dependent metallocarboxypeptidase. It cleaves C-terminal arginine or lysine from peptides including bradykinin (Km=16 µM, kcat=147 min⁻¹), Met⁵-Arg⁶-enkephalin (Km=46 µM, kcat=934 min⁻¹), dynorphin A(1-13), and enkephalin variants. The enzyme is activated by CoCl₂ and inhibited by o-phenanthroline and MMGPA, consistent with metallopeptidase identity; it is a glycoprotein with apparent Mr of 62,000 and is structurally, catalytically, and immunologically distinct from carboxypeptidases A, B, N, and H.","method":"Affinity purification, in vitro enzyme kinetics, inhibitor profiling, SDS-PAGE, concanavalin A binding, chemical deglycosylation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro enzymatic assay with full kinetic characterization and multiple orthogonal methods","pmids":["2914904"],"is_preprint":false},{"year":1989,"finding":"Molecular cloning of the human CPM cDNA revealed an open reading frame encoding 439 residues with an N-terminal signal peptide and a C-terminal hydrophobic region predicted to serve as a GPI-anchor signal. The sequence contains six potential N-linked glycosylation sites and conserved zinc-binding residues (two histidines and a glutamate) shared with other metallocarboxypeptidases. CPM shares 41% sequence identity with carboxypeptidase N and carboxypeptidase H (CPE), but only 15% with pancreatic CPA/B, placing it in the 'regulatory' carboxypeptidase subfamily.","method":"cDNA cloning and sequencing, hydropathic analysis, sequence alignment, N-terminal amino acid sequencing","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — direct cDNA sequencing with structural domain identification, confirmed by protein N-terminal sequence","pmids":["2753907"],"is_preprint":false},{"year":1993,"finding":"CPM is present at high concentrations in lung tissue (substantially higher than heart, liver, or kidney) and is localized by immunohistochemistry to alveolar type I pneumocytes and macrophages, but not type II alveolar epithelial cells. The enzyme is anchored to lung membranes via a phosphatidylinositol glycan (GPI) anchor, as demonstrated by release with bacterial phospholipase C. High CPM mRNA was confirmed by Northern blot in lung and placenta.","method":"Enzyme activity assay, immunoprecipitation, immunohistochemistry, phospholipase C treatment (GPI-anchor release), Northern blot","journal":"American journal of respiratory cell and molecular biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (enzymatic activity, immunohistochemistry, phospholipase C cleavage) in multiple species","pmids":["8338689"],"is_preprint":false},{"year":1995,"finding":"CPM was identified as the antigen recognized by monoclonal antibodies MAX.1 and MAX.11, which are almost undetectable on monocytes but highly expressed on differentiated macrophages. CPM expression and enzymatic activity markedly increase during in vitro monocyte-to-macrophage differentiation. Vitamin D3-induced monocytic differentiation of HL-60, U937, and THP-1 cell lines also upregulated CPM expression. Immunoaffinity purification with MAX.11 nearly completely depleted macrophage membrane preparations of CPM enzymatic activity, confirming identity.","method":"Immunoaffinity purification, N-terminal protein sequencing, enzymatic activity assay, mRNA quantification, antibody-mediated depletion, cell differentiation models","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal validation by enzymatic depletion and protein sequencing confirming antibody-antigen identity, replicated across multiple cell lines","pmids":["7797563"],"is_preprint":false},{"year":2000,"finding":"CPM expression is strongly induced during monocyte-to-macrophage differentiation in vitro and is expressed on macrophages in vivo during T-lymphocyte activation (e.g., allograft rejection, allergic alveolitis), suggesting CPM activity correlates with macrophage cytotoxic functions. Cloning of the murine CPM homologue revealed that mCPM is undetectable in murine primary macrophages and macrophage cell lines, indicating that CPM expression in macrophages is not conserved between human and mouse.","method":"mRNA expression analysis, immunohistochemistry of tissue sections, cDNA cloning (murine homologue), reverse transcription-PCR","journal":"Advances in experimental medicine and biology","confidence":"Medium","confidence_rationale":"Tier 3 — expression and localization data with in vivo tissue analysis, but limited functional mechanistic follow-up","pmids":["10849748"],"is_preprint":false},{"year":2001,"finding":"CPM mRNA and protein levels are significantly reduced in atrial tissue from patients with chronic persistent atrial fibrillation (CAF) compared to controls (CPM mRNA ~41 vs. ~86 arbitrary units; protein reduced to 47.5% of controls), suggesting that CPM-mediated bradykinin metabolism is altered during atrial fibrillation and may contribute to structural remodeling.","method":"Quantitative RT-PCR, protein expression analysis (Western/immunoblot), enzyme activity assay in human atrial tissue","journal":"Journal of molecular and cellular cardiology","confidence":"Medium","confidence_rationale":"Tier 3 — direct human tissue analysis with multiple methods, but correlative with no loss-of-function manipulation","pmids":["11444929"],"is_preprint":false},{"year":2004,"finding":"The 3.0 Å crystal structure of human GPI-free CPM was determined, revealing: (1) a 295-residue N-terminal catalytic domain similar to duck CPD-2; (2) an 86-residue β-sandwich C-terminal domain characteristic of the CPN/E family, more conically shaped than CPD-2; (3) a unique, partially disordered 25-residue C-terminal extension bearing the GPI-anchor attachment site. Modeling of Arg⁶-Met-enkephalin into the active site showed the S1' pocket is specifically shaped to accommodate P1'-Arg residues, explaining CPM's preference for cleaving C-terminal Arg over Lys.","method":"X-ray crystallography (3.0 Å), molecular modeling of substrate into active site","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — crystal structure determination with substrate modeling providing mechanistic basis for substrate specificity","pmids":["15066430"],"is_preprint":false},{"year":2008,"finding":"CPM is expressed by human bone marrow CD34⁺ hematopoietic stem/progenitor cells, myeloid/erythroid/megakaryocytic progenitors, mononuclear cells (MNC), polymorphonuclear cells (PMN), and stromal cells including mesenchymal stem cells. Recombinant CPM cleaves the C-terminal lysine of SDF-1α (1-68), yielding des-Lys SDF-1α (1-67). This CPM-mediated truncation reduces in vitro HSPC chemotaxis, an effect blocked by the carboxypeptidase inhibitor MMGPA. G-CSF significantly upregulates CPM expression in MNC and PMN, suggesting CPM participates in G-CSF-induced HSPC mobilization by attenuating the SDF-1α chemoattractant gradient.","method":"RT-PCR, Western blot, recombinant enzyme cleavage assay, HPLC/MS peptide analysis, in vitro chemotaxis assay, inhibitor rescue experiment, G-CSF stimulation of primary cells","journal":"Stem cells (Dayton, Ohio)","confidence":"High","confidence_rationale":"Tier 1–2 — reconstituted enzymatic cleavage of SDF-1α confirmed biochemically, functional consequence demonstrated in chemotaxis assay with inhibitor validation","pmids":["18292211"],"is_preprint":false},{"year":2008,"finding":"Somatic murine ACE (mACE) stably transfected in CHO or MDCK cells interacts with endogenous, co-localized GPI-anchored CPM, as demonstrated by co-immunoprecipitation and molecular/biochemical techniques. This interaction is independent of ACE's known dipeptidase activities. ACE proximity evokes release of CPM from the membrane, suggesting ACE has GPI-targeted properties and can act as a GPI-ase that releases GPI-anchored proteins such as CPM.","method":"Co-immunoprecipitation, stable transfection in CHO and MDCK cells, enzyme activity assays, cellular imaging","journal":"Biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP in cell-based system with functional readout (CPM release), single lab study","pmids":["18844448"],"is_preprint":false},{"year":2015,"finding":"CPM is highly expressed in embryonic liver progenitor cells (hepatoblasts) and is transiently induced during hepatic specification from human iPSCs. CPM⁺ cells isolated from differentiated hiPSCs at the immature hepatocyte stage proliferated extensively and expressed hepatoblast marker genes. These CPM⁺ cells differentiated into mature hepatocytes upon maturation induction and underwent cholangiocytic differentiation in 3D culture, demonstrating bi-potential progenitor capacity. Thus, CPM surface expression identifies and allows isolation of hiPSC-derived bi-potential liver progenitor cells.","method":"Flow cytometry cell sorting, colony formation/proliferation assays, gene expression profiling, hepatic maturation induction, 3D cholangiocytic differentiation culture, immunostaining","journal":"Stem cell reports","confidence":"High","confidence_rationale":"Tier 2 — prospective isolation using CPM as surface marker with functional bi-potential differentiation validated by multiple orthogonal methods","pmids":["26365514"],"is_preprint":false},{"year":2017,"finding":"CPM was identified as a direct target of miR-146a-5p in colorectal cancer cells. CPM expression inhibits migration and invasion of CRC cells. Both miR-146a-5p overexpression and CPM knockdown regulated Src and FAK phosphorylation/expression, placing CPM upstream of the Src-FAK signaling pathway. Restoration of CPM blocked miR-146a-5p-induced migration, establishing a functional miR-146a-5p/CPM/Src-FAK axis in CRC cell motility.","method":"Luciferase reporter assay (direct target validation), siRNA/overexpression cell migration and invasion assays, Western blot for Src/FAK pathway components, rescue experiments","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2–3 — direct target validation by luciferase assay, epistasis by rescue experiment, single lab study","pmids":["28186967"],"is_preprint":false},{"year":2019,"finding":"A functional SNP in the CPM gene promoter region (rs12812500 G allele) is significantly associated with increased silicosis susceptibility. Luciferase reporter gene assays demonstrated that the mutant G allele drives significantly higher CPM promoter activity than the wild-type C allele, indicating the variant increases CPM transcription and may contribute to silicosis susceptibility through elevated CPM expression in lung tissue.","method":"Case-control association study, luciferase reporter gene assay with promoter variants, mRNA expression in peripheral blood leukocytes","journal":"Occupational and environmental medicine","confidence":"Medium","confidence_rationale":"Tier 2–3 — luciferase reporter assay provides direct functional evidence for SNP effect on promoter activity, supported by expression data","pmids":["30674606"],"is_preprint":false},{"year":2003,"finding":"CPM was identified as a GPI-anchored protein in a human lipid raft-enriched membrane fraction by a mass spectrometry-based proteomics strategy, confirming its GPI-anchored membrane localization in intact cells.","method":"Biochemical enrichment of lipid raft fractions, mass spectrometry proteomics, computational GPI-anchor sequence analysis","journal":"Molecular & cellular proteomics : MCP","confidence":"Medium","confidence_rationale":"Tier 2 — experimental confirmation of GPI-anchor localization by lipid-raft proteomics and MS, consistent with prior biochemical data","pmids":["14517339"],"is_preprint":false},{"year":2006,"finding":"CPM was identified among 11 human GPI-anchored proteins released from plasma membrane fractions by phospholipase D (PLD) treatment, further confirming its GPI-anchor membrane attachment. Unlike phospholipase C, PLD is not affected by GPI structural heterogeneity, validating CPM's GPI-AP status across different structural GPI variants.","method":"Phospholipase D treatment of human plasma membrane fractions, capillary LC-MS/MS proteomics","journal":"Journal of proteome research","confidence":"Medium","confidence_rationale":"Tier 2 — enzymatic release and MS identification provide direct experimental confirmation of GPI anchoring","pmids":["16602701"],"is_preprint":false}],"current_model":"Carboxypeptidase M (CPM) is a GPI-anchored, zinc-dependent metallocarboxypeptidase on the extracellular plasma membrane surface that cleaves C-terminal basic residues (Arg > Lys) from peptide hormones and growth factors including bradykinin, enkephalins, and SDF-1α, thereby modulating their biological activity; its crystal structure reveals a CPN/E-subfamily catalytic domain with an S1' pocket preferentially accommodating Arg, it is strongly induced during monocyte-to-macrophage differentiation and in embryonic hepatoblasts/hiPSC-derived liver progenitors, it interacts with and is released by ACE in a GPI-ase-dependent manner, and in colorectal cancer cells it suppresses migration by acting upstream of the Src-FAK signaling pathway."},"narrative":{"teleology":[{"year":1989,"claim":"Biochemical purification and cDNA cloning established CPM as a novel membrane-bound zinc metallocarboxypeptidase distinct from all previously known carboxypeptidases, with full kinetic parameters for bradykinin and enkephalin substrates and a predicted GPI-anchor signal in its primary sequence.","evidence":"Affinity purification from human placental microvilli with in vitro kinetics; cDNA cloning and sequence analysis","pmids":["2914904","2753907"],"confidence":"High","gaps":["GPI anchoring predicted from sequence but not yet experimentally verified","No structural basis for substrate specificity","In vivo physiological substrates and tissue distribution not yet established"]},{"year":1993,"claim":"Experimental confirmation that CPM is GPI-anchored and identification of lung as the tissue with highest expression resolved the membrane attachment mechanism and pointed to respiratory and inflammatory biology as key contexts.","evidence":"Phospholipase C release from lung membranes, immunohistochemistry localizing CPM to alveolar type I pneumocytes and macrophages, Northern blot","pmids":["8338689"],"confidence":"High","gaps":["Functional role of CPM in alveolar biology not tested","No lipid-raft or microdomain localization data yet"]},{"year":1995,"claim":"Identification of CPM as the MAX.1/MAX.11 macrophage differentiation antigen established that CPM expression is strongly induced during monocyte-to-macrophage differentiation, linking the enzyme to innate immune cell maturation.","evidence":"Immunoaffinity purification, N-terminal sequencing, enzymatic activity depletion, monocyte differentiation in vitro and in HL-60/U937/THP-1 cell lines","pmids":["7797563"],"confidence":"High","gaps":["Mechanism by which CPM is transcriptionally upregulated during differentiation unknown","Functional consequence of CPM activity on macrophage effector functions not tested"]},{"year":2003,"claim":"Proteomic and enzymatic approaches confirmed CPM resides in lipid-raft membrane domains via GPI anchoring, extending the biochemical verification across orthogonal methods and GPI structural variants.","evidence":"Lipid raft proteomics (MS) and phospholipase D release from plasma membrane fractions with LC-MS/MS","pmids":["14517339","16602701"],"confidence":"Medium","gaps":["Whether raft localization influences substrate access or enzymatic activity not examined","Dynamics of GPI-anchor remodeling in vivo unknown"]},{"year":2004,"claim":"The crystal structure of CPM at 3.0 Å resolution explained the enzyme's Arg-over-Lys specificity by revealing a CPN/E-family catalytic domain with an S1' pocket shaped to accommodate arginine, providing the first structural framework for understanding substrate selectivity.","evidence":"X-ray crystallography at 3.0 Å with molecular modeling of Arg⁶-Met-enkephalin into the active site","pmids":["15066430"],"confidence":"High","gaps":["No co-crystal with bound substrate or transition-state analog","Structural basis for GPI-anchor attachment region disordered and unresolved"]},{"year":2008,"claim":"CPM was shown to cleave SDF-1α and attenuate hematopoietic stem/progenitor cell chemotaxis, establishing a physiological substrate beyond bradykinin/enkephalins and implicating CPM in G-CSF-induced stem cell mobilization; separately, ACE was found to physically interact with and release GPI-anchored CPM from the membrane.","evidence":"Recombinant CPM cleavage of SDF-1α confirmed by HPLC/MS, chemotaxis assay with inhibitor rescue; Co-IP of ACE and CPM in transfected CHO/MDCK cells","pmids":["18292211","18844448"],"confidence":"High","gaps":["In vivo validation of CPM-SDF-1α axis in stem cell mobilization not performed","ACE–CPM interaction demonstrated in overexpression system; endogenous reciprocal validation lacking","Mechanism of ACE-mediated GPI-ase activity not defined"]},{"year":2015,"claim":"CPM surface expression was shown to mark bipotential liver progenitor cells (hepatoblasts) during human iPSC-to-hepatocyte differentiation, enabling prospective isolation of cells capable of both hepatocyte and cholangiocyte maturation.","evidence":"FACS sorting of CPM⁺ cells from differentiated hiPSCs, colony formation, hepatic maturation, and 3D cholangiocytic differentiation","pmids":["26365514"],"confidence":"High","gaps":["Whether CPM enzymatic activity is functionally required for hepatic progenitor specification is unknown","Transcriptional regulation of CPM induction during hepatic specification not dissected"]},{"year":2017,"claim":"In colorectal cancer cells, CPM was identified as a direct miR-146a-5p target that suppresses migration by acting upstream of Src–FAK signaling, extending CPM's biological roles beyond peptide metabolism to tumor cell motility.","evidence":"Luciferase reporter target validation, siRNA knockdown and overexpression migration/invasion assays, Western blot for Src/FAK, rescue experiments in CRC cell lines","pmids":["28186967"],"confidence":"Medium","gaps":["Whether the anti-migratory effect requires CPM catalytic activity or a non-enzymatic mechanism is untested","The specific CPM substrate(s) relevant to Src–FAK regulation are unidentified","Single-lab finding without in vivo tumor model validation"]},{"year":2019,"claim":"A promoter SNP (rs12812500) was functionally linked to increased CPM transcription and silicosis susceptibility, connecting CPM expression levels in lung to occupational lung disease risk.","evidence":"Case-control genetic association study with functional luciferase reporter assay for allele-specific promoter activity","pmids":["30674606"],"confidence":"Medium","gaps":["Mechanism by which elevated CPM expression promotes silicosis pathology not defined","Replication in independent cohorts not reported","No loss-of-function or animal model validation"]},{"year":null,"claim":"Key open questions include whether CPM catalytic activity is required for its roles in macrophage function and tumor suppression, what the full in vivo substrate repertoire is, and how CPM expression is transcriptionally regulated during differentiation and disease.","evidence":"","pmids":[],"confidence":"High","gaps":["No catalytically dead knock-in study to separate enzymatic from non-enzymatic roles","No in vivo knockout phenotype reported","No substrate co-crystal structure available"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,6,7]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,6,7]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,1,2,12,13]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3,4,7]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[7,10]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,6,7]}],"complexes":[],"partners":["ACE","SDF1","SRC","FAK"],"other_free_text":[]},"mechanistic_narrative":"Carboxypeptidase M (CPM) is a GPI-anchored, zinc-dependent metallocarboxypeptidase that resides on the extracellular face of the plasma membrane and cleaves C-terminal basic residues (Arg > Lys) from peptide substrates including bradykinin, enkephalins, and SDF-1α, thereby modulating peptide hormone signaling and chemotactic gradients [PMID:2914904, PMID:18292211]. Its crystal structure reveals a CPN/E-subfamily catalytic domain with an S1' pocket that preferentially accommodates arginine, explaining the Arg-over-Lys selectivity [PMID:15066430]. CPM is strongly induced during monocyte-to-macrophage differentiation and serves as a surface marker of bipotential hepatic progenitor cells derived from human iPSCs [PMID:7797563, PMID:26365514]. In colorectal cancer cells, CPM suppresses migration by acting upstream of the Src–FAK signaling pathway [PMID:28186967]."},"prefetch_data":{"uniprot":{"accession":"P14384","full_name":"Carboxypeptidase M","aliases":[],"length_aa":443,"mass_kda":50.5,"function":"Specifically removes C-terminal basic residues (Arg or Lys) from peptides and proteins. It is believed to play important roles in the control of peptide hormone and growth factor activity at the cell surface, and in the membrane-localized degradation of extracellular proteins","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P14384/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CPM","classification":"Not Classified","n_dependent_lines":19,"n_total_lines":1208,"dependency_fraction":0.015728476821192054},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CPM","total_profiled":1310},"omim":[{"mim_id":"612309","title":"COAGULATION FACTOR V; F5","url":"https://www.omim.org/entry/612309"},{"mim_id":"608859","title":"CD109 ANTIGEN; CD109","url":"https://www.omim.org/entry/608859"},{"mim_id":"602981","title":"AE-BINDING PROTEIN 1; AEBP1","url":"https://www.omim.org/entry/602981"},{"mim_id":"602396","title":"ANNEXIN A8; ANXA8","url":"https://www.omim.org/entry/602396"},{"mim_id":"601709","title":"QUEBEC PLATELET DISORDER; QPD","url":"https://www.omim.org/entry/601709"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Vesicles","reliability":"Uncertain"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"adipose tissue","ntpm":146.3}],"url":"https://www.proteinatlas.org/search/CPM"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P14384","domains":[{"cath_id":"3.40.630.10","chopping":"26-313","consensus_level":"high","plddt":97.4116,"start":26,"end":313},{"cath_id":"2.60.40.1120","chopping":"316-394","consensus_level":"high","plddt":94.3409,"start":316,"end":394}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P14384","model_url":"https://alphafold.ebi.ac.uk/files/AF-P14384-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P14384-F1-predicted_aligned_error_v6.png","plddt_mean":90.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CPM","jax_strain_url":"https://www.jax.org/strain/search?query=CPM"},"sequence":{"accession":"P14384","fasta_url":"https://rest.uniprot.org/uniprotkb/P14384.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P14384/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P14384"}},"corpus_meta":[{"pmid":"35075806","id":"PMC_35075806","title":"Circular CPM promotes chemoresistance of gastric cancer via activating PRKAA2-mediated autophagy.","date":"2022","source":"Clinical and translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35075806","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21950461","id":"PMC_21950461","title":"An FCS study of unfolding and refolding of CPM-labeled human serum albumin: role of ionic liquid.","date":"2011","source":"The journal of physical chemistry. B","url":"https://pubmed.ncbi.nlm.nih.gov/21950461","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26365514","id":"PMC_26365514","title":"CPM Is a Useful Cell Surface Marker to Isolate Expandable Bi-Potential Liver Progenitor Cells Derived from Human iPS Cells.","date":"2015","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26365514","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21120258","id":"PMC_21120258","title":"Treatment of facial atrophic scars with Esthélis, a hyaluronic acid filler with polydense cohesive matrix (CPM).","date":"2010","source":"Journal of drugs in dermatology : JDD","url":"https://pubmed.ncbi.nlm.nih.gov/21120258","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12224065","id":"PMC_12224065","title":"CGH in the detection of confined placental mosaicism (CPM) in placentas of abnormal pregnancies.","date":"2002","source":"Prenatal diagnosis","url":"https://pubmed.ncbi.nlm.nih.gov/12224065","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10849748","id":"PMC_10849748","title":"The membrane-bound ectopeptidase CPM as a marker of macrophage maturation in vitro and in vivo.","date":"2000","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/10849748","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10073903","id":"PMC_10073903","title":"Trisomy 15 CPM: probable origins, pregnancy outcome and risk of fetal UPD: European Collaborative Research on Mosaicism in CVS (EUCROMIC).","date":"1999","source":"Prenatal diagnosis","url":"https://pubmed.ncbi.nlm.nih.gov/10073903","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29633605","id":"PMC_29633605","title":"COMPARE CPM-RMI Trial: Intramyocardial Transplantation of Autologous Bone Marrow-Derived CD133+ Cells and MNCs during CABG in Patients with Recent MI: A Phase II/III, Multicenter, Placebo-Controlled, Randomized, Double-Blind Clinical Trial.","date":"2018","source":"Cell journal","url":"https://pubmed.ncbi.nlm.nih.gov/29633605","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3753786","id":"PMC_3753786","title":"Assembly of overlapping DNA sequences by a program written in BASIC for 64K CP/M and MS-DOS IBM-compatible microcomputers.","date":"1986","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/3753786","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30674606","id":"PMC_30674606","title":"Functional variant of the carboxypeptidase M (CPM) gene may affect silica-related pneumoconiosis susceptibility by its expression: a multistage case-control study.","date":"2019","source":"Occupational and environmental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30674606","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18052771","id":"PMC_18052771","title":"Current perspectives in the management of hyponatremia: prevention of CPM.","date":"2007","source":"Expert review of neurotherapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/18052771","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32159280","id":"PMC_32159280","title":"Differences in physician opinions about controversial issues surrounding contralateral prophylactic mastectomy (CPM): A survey of physicians from accredited breast centers in the United States.","date":"2020","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32159280","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31549121","id":"PMC_31549121","title":"Two is better than one: difunctional high-affinity PSMA probes based on a [CpM(CO)3] (M = Re/99mTc) scaffold.","date":"2019","source":"Dalton transactions (Cambridge, England : 2003)","url":"https://pubmed.ncbi.nlm.nih.gov/31549121","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25772562","id":"PMC_25772562","title":"Cysteine residue is not essential for CPM protein thermal-stability assay.","date":"2015","source":"Analytical and bioanalytical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25772562","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12098319","id":"PMC_12098319","title":"Relative efficiencies of CpM(CO)(n)CH(3) and CpM(CO)(n)Ph (M = Cr, Mo, W, and Fe) complexes in photoinduced DNA cleavage.","date":"2002","source":"The Journal of organic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12098319","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35163736","id":"PMC_35163736","title":"The Barley Chloroplast Mutator (cpm) Mutant: All Roads Lead to the Msh1 Gene.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35163736","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7680715","id":"PMC_7680715","title":"Pharmacological study of 14 beta-(thioglycolamido)-7,8-dihydro-N(cyclopropylmethyl)-normor phinone (N-CPM-TAMO).","date":"1993","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/7680715","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27054097","id":"PMC_27054097","title":"Nanodisc-Tm: Rapid functional assessment of nanodisc reconstituted membrane proteins by CPM assay.","date":"2016","source":"MethodsX","url":"https://pubmed.ncbi.nlm.nih.gov/27054097","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31166238","id":"PMC_31166238","title":"Toxicologic and Inhibitory Receptor Actions of the Etomidate Analog ABP-700 and Its Metabolite CPM-Acid.","date":"2019","source":"Anesthesiology","url":"https://pubmed.ncbi.nlm.nih.gov/31166238","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18844448","id":"PMC_18844448","title":"Interaction of angiotensin-converting enzyme (ACE) with membrane-bound carboxypeptidase M (CPM) - a new function of ACE.","date":"2008","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18844448","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24216152","id":"PMC_24216152","title":"Common Prairie feeds with different soluble and insoluble fractions used for CPM diet formulation in dairy cattle: impact of carbohydrate-protein matrix structure on protein and other primary nutrient digestion.","date":"2013","source":"Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy","url":"https://pubmed.ncbi.nlm.nih.gov/24216152","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33790641","id":"PMC_33790641","title":"Conditioned Pain Modulation (CPM) Effects Captured in Facial Expressions.","date":"2021","source":"Journal of pain research","url":"https://pubmed.ncbi.nlm.nih.gov/33790641","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32021827","id":"PMC_32021827","title":"In ovo technique for cell injection in the CPM followed by bead implantation in the BA2 of chicken embryos.","date":"2020","source":"MethodsX","url":"https://pubmed.ncbi.nlm.nih.gov/32021827","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29845801","id":"PMC_29845801","title":"COMPARE CPM-RMI Trial: Intramyocardial Transplantation of Autologous Bone Marrow-Derived CD133+ Cells and MNCs during CABG in Patients with Recent MI: A Phase II/III, Multicenter, Placebo-Controlled, Randomized, Double-Blind Clinical Trial.","date":"2018","source":"Cell journal","url":"https://pubmed.ncbi.nlm.nih.gov/29845801","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19882104","id":"PMC_19882104","title":"CPm gene diversity in field isolates of Citrus tristeza virus from Colombia.","date":"2009","source":"Archives of virology","url":"https://pubmed.ncbi.nlm.nih.gov/19882104","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"999456","id":"PMC_999456","title":"Combination of ametopterine (MTX) and cyclophosphamide (CPM) based on the principle of partial synchronization of cell proliferation in lung cancer. Phase II study.","date":"1976","source":"Archiv fur Geschwulstforschung","url":"https://pubmed.ncbi.nlm.nih.gov/999456","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32301146","id":"PMC_32301146","title":"Identification of genetic effects and potential causal polymorphisms of CPM gene impacting milk fatty acid traits in Chinese Holstein.","date":"2020","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32301146","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16114497","id":"PMC_16114497","title":"Purification and characterization of a serine protease (CPM-2) with fibrinolytic activity from the dung beetles.","date":"2005","source":"Archives of pharmacal research","url":"https://pubmed.ncbi.nlm.nih.gov/16114497","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34494949","id":"PMC_34494949","title":"Plasticity of the lettuce infectious yellows virus minor coat protein (CPm) in mediating the foregut retention and transmission of a chimeric CPm mutant by whitefly vectors.","date":"2021","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/34494949","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37056753","id":"PMC_37056753","title":"Tomato chlorosis virus CPm protein is a pathogenicity determinant and suppresses host local RNA silencing induced by single-stranded RNA.","date":"2023","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/37056753","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40887166","id":"PMC_40887166","title":"A fluorescent CPM-based in vitro acetylation assay: A tool for assessing N-terminal acetyltransferase activity and profiling compound activity.","date":"2025","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/40887166","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40943564","id":"PMC_40943564","title":"Four Large Indels in Barley Chloroplast Mutator (cpm) Seedlings Reinforce the Hypothesis of a Malfunction in the MMR System.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40943564","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14535623","id":"PMC_14535623","title":"Effects of structural modifications of N-CPM-normorphine derivatives on agonist and antagonist activities in isolated organs.","date":"2003","source":"Acta biologica Hungarica","url":"https://pubmed.ncbi.nlm.nih.gov/14535623","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.09.29.25336881","title":"Cuff Algometry Induces Large Yet Variable Conditioned Pain Modulation Effects","date":"2025-10-07","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.29.25336881","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.09.25.25332983","title":"Post-Spinal Mobilization Conditioned Pain Modulation Stratifies Recovery Trajectories in Chronic Neck Pain: Toward a Mechanism-Informed Biomarker for Precision Rehabilitation","date":"2025-10-02","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.25.25332983","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.10.14.680967","title":"Integrative Structure and Function of the <i>Vibrio cholerae</i> Competence Pilus Machine","date":"2025-10-14","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.14.680967","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.08.22.671789","title":"Uncovering Developmental Lineages from Single-cell Data with Contrastive Poincaré Maps","date":"2025-08-27","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.22.671789","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.10.02.680080","title":"Transdiagnostic connectome-based predictive modeling of many behavioral phenotypes reveals brain network mediators of clinical-cognitive relationships","date":"2025-10-02","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.02.680080","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.07.28.25332334","title":"The effect of age on survival in patients with peritoneal metastases from colorectal cancer who were treated with CRS-HIPEC","date":"2025-07-29","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.28.25332334","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.04.26.650748","title":"GTEx_Pro: A robust and accurate preprocessing pipeline for GTEx data: TMM+CPM normalization and SVA batch correction for enhanced multi-tissue analysis","date":"2025-04-29","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.26.650748","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.11.16.25340328","title":"Early-life exposure to air pollution alters resting-state functional connectivity patterns in late childhood","date":"2025-11-17","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.16.25340328","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.01.30.635646","title":"Profiling trait and state-like behaviour in pain modulation systems: a role for effective connectivity within endogenous pain control circuits","date":"2025-01-30","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.30.635646","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.05.23.25328210","title":"A Proof-of-Concept Clinical Trial Design for Evolutionary Guided Precision Medicine for Cancer","date":"2025-05-23","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.23.25328210","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.03.07.642007","title":"Towards Clinical Phage Microbiology for Biofilm Infections: A Comparative Study and a Suggested Protocol","date":"2025-03-10","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.07.642007","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.06.09.25329238","title":"Part 2: Predicting heterogeneity of treatment effects to transcranial direct current stimulation for knee osteoarthritis pain and symptoms","date":"2025-06-09","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.09.25329238","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.08.26.672253","title":"Connectome-based predictive modelling predicts frailty levels in older adults","date":"2025-08-31","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.26.672253","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.09.17.25336005","title":"Transdiagnostic similarities and distinctions in brain networks associated with ASD symptoms: A prospective cohort study","date":"2025-09-18","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.17.25336005","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20360068","id":"PMC_20360068","title":"Systematic analysis of human protein complexes identifies chromosome segregation proteins.","date":"2010","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/20360068","citation_count":421,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8889548","id":"PMC_8889548","title":"Normalization and subtraction: two approaches to facilitate gene discovery.","date":"1996","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/8889548","citation_count":401,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20673876","id":"PMC_20673876","title":"Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression.","date":"2010","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/20673876","citation_count":150,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14517339","id":"PMC_14517339","title":"Proteomic analysis of glycosylphosphatidylinositol-anchored membrane proteins.","date":"2003","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/14517339","citation_count":146,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19322201","id":"PMC_19322201","title":"Ubiquitin-mediated proteolysis of HuR by heat shock.","date":"2009","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/19322201","citation_count":142,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23533145","id":"PMC_23533145","title":"In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.","date":"2013","source":"Proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/23533145","citation_count":138,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11375929","id":"PMC_11375929","title":"Diverse transcriptional initiation revealed by fine, large-scale mapping of mRNA start sites.","date":"2001","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/11375929","citation_count":131,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23376485","id":"PMC_23376485","title":"Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.","date":"2013","source":"Journal of proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/23376485","citation_count":126,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2914904","id":"PMC_2914904","title":"Human carboxypeptidase M. Purification and characterization of a membrane-bound carboxypeptidase that cleaves peptide hormones.","date":"1989","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2914904","citation_count":120,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34857952","id":"PMC_34857952","title":"Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.","date":"2021","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34857952","citation_count":116,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18029348","id":"PMC_18029348","title":"Toward a confocal subcellular atlas of the human proteome.","date":"2007","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/18029348","citation_count":114,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19581412","id":"PMC_19581412","title":"Quantitative proteomics identifies a Dab2/integrin module regulating cell migration.","date":"2009","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19581412","citation_count":101,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29478914","id":"PMC_29478914","title":"Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS.","date":"2018","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/29478914","citation_count":101,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2753907","id":"PMC_2753907","title":"Molecular cloning and sequencing of the cDNA for human membrane-bound carboxypeptidase M. Comparison with carboxypeptidases A, B, H, and N.","date":"1989","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2753907","citation_count":92,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16602701","id":"PMC_16602701","title":"Modification-specific proteomics of plasma membrane proteins: identification and characterization of glycosylphosphatidylinositol-anchored proteins released upon phospholipase D treatment.","date":"2006","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/16602701","citation_count":90,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31586073","id":"PMC_31586073","title":"The midbody interactome reveals unexpected roles for PP1 phosphatases in cytokinesis.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31586073","citation_count":74,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8338689","id":"PMC_8338689","title":"High concentration of carboxypeptidase M in lungs: presence of the enzyme in alveolar type I cells.","date":"1993","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8338689","citation_count":67,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7797563","id":"PMC_7797563","title":"Carboxypeptidase M is identical to the MAX.1 antigen and its expression is associated with monocyte to macrophage differentiation.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7797563","citation_count":60,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18292211","id":"PMC_18292211","title":"Carboxypeptidase M expressed by human bone marrow cells cleaves the C-terminal lysine of stromal cell-derived factor-1alpha: another player in hematopoietic stem/progenitor cell mobilization?","date":"2008","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/18292211","citation_count":52,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19820690","id":"PMC_19820690","title":"Carboxypeptidase M: a biomarker for the discrimination of well-differentiated liposarcoma from lipoma.","date":"2009","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/19820690","citation_count":52,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28186967","id":"PMC_28186967","title":"MicroRNA-146a promote cell migration and invasion in human colorectal cancer via carboxypeptidase M/src-FAK pathway.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28186967","citation_count":52,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15066430","id":"PMC_15066430","title":"Crystal structure of human carboxypeptidase M, a membrane-bound enzyme that regulates peptide hormone activity.","date":"2004","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15066430","citation_count":50,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11444929","id":"PMC_11444929","title":"Expression and activity of ectopeptidases in fibrillating human atria.","date":"2001","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/11444929","citation_count":42,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":23555,"output_tokens":1048,"usd":0.043193},"stage2":{"model":"claude-opus-4-6","input_tokens":4253,"output_tokens":1429,"usd":0.085485},"total_usd":0.381473,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":37295,"output_tokens":5987,"usd":0.100845},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":7685,"output_tokens":2515,"usd":0.15195}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"Carboxypeptidase M (CPM) is a GPI-anchored membrane-bound ectopeptidase expressed on human macrophages that processes immunologically important peptides including bradykinin, anaphylatoxins, and enkephalins; its expression is induced during monocyte-to-macrophage maturation and correlates with macrophage cytotoxic function.\",\n      \"method\": \"Antibody-based identification (mAb MAX.1/MAX.11), in vitro maturation assays, substrate cleavage assays, cDNA cloning of murine homologue\",\n      \"journal\": \"Advances in experimental medicine and biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods (antibody detection, substrate assays, cDNA cloning) in single lab; foundational characterization paper\",\n      \"pmids\": [\"10849748\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Angiotensin-converting enzyme (ACE) physically interacts with the GPI-anchored carboxypeptidase M (CPM) at the cell membrane, and this interaction — independent of ACE's dipeptidase activity — leads to ACE-evoked release of CPM, suggesting ACE has GPI-targeted properties mediated through spatial proximity with CPM.\",\n      \"method\": \"Molecular, biochemical, and cellular techniques including stable transfection of murine ACE in CHO and MDCK cells, co-localization studies, functional release assays\",\n      \"journal\": \"Biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (transfection, co-localization, release assay) in single lab\",\n      \"pmids\": [\"18844448\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CPM (carboxypeptidase M) is highly expressed on hepatoblasts and liver progenitor cells during embryonic liver development and is transiently induced during hepatic specification from human iPSCs; CPM+ cells isolated from differentiated hiPSCs exhibit bi-potential liver progenitor characteristics, proliferating extensively and differentiating into both hepatocytes and cholangiocytes.\",\n      \"method\": \"Cell surface marker isolation, in vitro differentiation assays, three-dimensional culture for cholangiocytic differentiation, gene expression profiling\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean cell isolation with defined functional phenotypic readouts (proliferation + bi-directional differentiation), single lab but multiple orthogonal assays\",\n      \"pmids\": [\"26365514\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A functional variant (rs12812500) in the CPM gene promoter region increases CPM transcriptional activity, as demonstrated by luciferase reporter assay showing that the mutant G allele drives higher luciferase expression compared to wild-type C allele, and is associated with increased CPM mRNA expression in peripheral blood leucocytes of silicosis patients.\",\n      \"method\": \"Luciferase reporter gene assay, case-control mRNA expression analysis\",\n      \"journal\": \"Occupational and environmental medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, reporter assay without mutagenesis validation or protein-level functional follow-up\",\n      \"pmids\": [\"30674606\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Carboxypeptidase M (CPM) is a GPI-anchored membrane-bound ectopeptidase that cleaves C-terminal basic amino acids from peptide substrates including bradykinin, anaphylatoxins, and enkephalins; it is upregulated during monocyte-to-macrophage maturation and during hepatic progenitor specification, physically interacts with ACE at the cell surface leading to ACE-mediated CPM release, and its promoter activity is regulated by functional genetic variants.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper first, then extract discoveries only from KEPT papers about the canonical human CPM (carboxypeptidase M) protein.\n\n**Classification:**\n- KEEP: Papers about canonical human/mammalian CPM (carboxypeptidase M) protein\n- EXCLUDE: Papers about circCPM (circRNA - alt-locus product), CPM as fluorescent dye/probe, confined placental mosaicism, contralateral prophylactic mastectomy, conditioned pain modulation, central pontine myelinolysis, barley chloroplast mutator, citrus tristeza virus coat protein, COMPARE CPM-RMI trial, connectome-based predictive modeling, crinivirus CPm, dung beetle protease, CP/M operating system, organometallic chemistry, cattle feed, other unrelated uses of \"CPM\" acronym\n\n**KEPT papers:**\n- PMID:26365514 (CPM as liver progenitor cell marker - canonical CPM)\n- PMID:10849748 (CPM as macrophage maturation antigen - canonical CPM)\n- PMID:2914904 (purification and characterization of human CPM - canonical CPM)\n- PMID:2753907 (molecular cloning of human CPM cDNA - canonical CPM)\n- PMID:8338689 (CPM in lungs - canonical CPM)\n- PMID:7797563 (CPM = MAX.1 antigen, monocyte-macrophage differentiation - canonical CPM)\n- PMID:18292211 (CPM cleaves SDF-1alpha - canonical CPM)\n- PMID:19820690 (CPM as biomarker for liposarcoma - canonical CPM)\n- PMID:28186967 (miR-146a/CPM/Src-FAK axis - canonical CPM)\n- PMID:15066430 (crystal structure of human CPM - canonical CPM)\n- PMID:18844448 (ACE interacts with CPM - canonical CPM)\n- PMID:11444929 (ectopeptidases in atrial fibrillation - canonical CPM)\n- PMID:14517339 (GPI-anchored protein proteomics - canonical CPM identified)\n- PMID:16602701 (GPI-AP proteomics with PLD - canonical CPM)\n- PMID:30674606 (CPM gene variant in silicosis - canonical CPM, functional promoter assay)\n- PMID:32301146 (CPM gene dairy cattle SNPs - KEEP as ortholog context, but mainly GWAS/expression - minimal mechanistic content)\n- PMID:20673876 (GWAS for depression implicating CPM locus - exclude, no mechanistic finding about CPM protein)\n\n**EXCLUDED:**\n- PMID:35075806 (circCPM - alt-locus circRNA product)\n- PMID:21950461 (CPM = fluorescent dye label)\n- PMID:21120258 (CPM = cohesive matrix technology)\n- PMID:12224065 (CPM = confined placental mosaicism)\n- PMID:10073903 (CPM = confined placental mosaicism)\n- PMID:29633605, 29845801 (COMPARE CPM-RMI trial)\n- PMID:3753786 (CP/M operating system)\n- PMID:18052771 (CPM = central pontine myelinolysis)\n- PMID:32159280 (CPM = contralateral prophylactic mastectomy)\n- PMID:31549121 (CpM = organometallic chemistry)\n- PMID:35163736, 40943564 (barley cpm = chloroplast mutator)\n- PMID:7680715, 14535623 (N-CPM = N-cyclopropylmethyl opioid derivatives)\n- PMID:25772562 (CPM = fluorescent dye assay)\n- PMID:27054097 (CPM = fluorescent dye assay)\n- PMID:12098319 (CpM = organometallic)\n- PMID:16114497 (CPM-2 = dung beetle protease)\n- PMID:34494949 (CPm = crinivirus coat protein)\n- PMID:37056753 (CPm = tomato chlorosis virus)\n- PMID:19882104 (CPm = citrus tristeza virus)\n- PMID:999456 (CPM = cyclophosphamide)\n- PMID:24216152 (CPM = cattle feed protein)\n- PMID:31166238 (CPM-acid = etomidate metabolite)\n- PMID:32021827 (CPM = cranial paraxial mesoderm)\n- PMID:33790641, bio_10.1101_2025.09.29.25336881, bio_10.1101_2025.09.25.25332983, bio_10.1101_2025.01.30.635646, bio_10.1101_2025.06.09.25329238 (CPM = conditioned pain modulation)\n- bio_10.1101_2025.10.14.680967 (CPM = competence pilus machine)\n- bio_10.1101_2025.08.22.671789 (CPM = Contrastive Poincaré Maps)\n- bio_10.1101_2025.10.02.680080, bio_10.1101_2025.08.26.672253, bio_10.1101_2025.09.17.25336005 (CPM = connectome-based predictive modeling)\n- bio_10.1101_2025.04.26.650748 (CPM = normalization method)\n- bio_10.1101_2025.07.28.25332334 (CPM = colorectal peritoneal metastases)\n- bio_10.1101_2025.11.16.25340328 (CPM = connectome-based predictive modeling)\n- bio_10.1101_2025.05.23.25328210 (CPM = Current Precision Medicine)\n- bio_10.1101_2025.03.07.642007 (CPM = Clinical Phage Microbiology)\n- PMID:40887166 (CPM = fluorescent dye for NAT assay)\n- PMID:20673876 (GWAS - no mechanistic finding about CPM protein itself)\n- PMID:28514442, 26496610, 33961781 (BioPlex interactome - CPM detected but no specific mechanistic finding extracted)\n- PMID:20360068 (chromosome segregation - no CPM specific finding)\n- PMID:19322201 (HuR ubiquitination - no CPM)\n- PMID:19581412 (Dab2/integrin - no CPM)\n- PMID:29478914 (DCPS/AML - no CPM)\n- PMID:34857952 (DUSP4/6 - no CPM)\n- PMID:31586073 (midbody interactome - no CPM)\n- PMID:12477932, 15489334 (MGC cDNA collections - no specific CPM mechanism)\n- PMID:21873635 (GO phylogenetic annotation - no specific CPM mechanism)\n- PMID:8889548 (cDNA normalization - no CPM)\n- PMID:16344560 (alternative promoters - no specific CPM mechanism)\n- PMID:11375929 (transcriptional start sites - no specific CPM mechanism)\n- PMID:18029348 (subcellular atlas - no specific CPM mechanism)\n- PMID:23533145 (prostatic exosome proteomics - CPM detected, no mechanism)\n- PMID:23376485 (podocyte exosome proteomics - CPM detected, no mechanism)\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1989,\n      \"finding\": \"Human carboxypeptidase M (CPM) was purified to homogeneity from placental microvilli and characterized as a membrane-bound zinc-dependent metallocarboxypeptidase. It cleaves C-terminal arginine or lysine from peptides including bradykinin (Km=16 µM, kcat=147 min⁻¹), Met⁵-Arg⁶-enkephalin (Km=46 µM, kcat=934 min⁻¹), dynorphin A(1-13), and enkephalin variants. The enzyme is activated by CoCl₂ and inhibited by o-phenanthroline and MMGPA, consistent with metallopeptidase identity; it is a glycoprotein with apparent Mr of 62,000 and is structurally, catalytically, and immunologically distinct from carboxypeptidases A, B, N, and H.\",\n      \"method\": \"Affinity purification, in vitro enzyme kinetics, inhibitor profiling, SDS-PAGE, concanavalin A binding, chemical deglycosylation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro enzymatic assay with full kinetic characterization and multiple orthogonal methods\",\n      \"pmids\": [\"2914904\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"Molecular cloning of the human CPM cDNA revealed an open reading frame encoding 439 residues with an N-terminal signal peptide and a C-terminal hydrophobic region predicted to serve as a GPI-anchor signal. The sequence contains six potential N-linked glycosylation sites and conserved zinc-binding residues (two histidines and a glutamate) shared with other metallocarboxypeptidases. CPM shares 41% sequence identity with carboxypeptidase N and carboxypeptidase H (CPE), but only 15% with pancreatic CPA/B, placing it in the 'regulatory' carboxypeptidase subfamily.\",\n      \"method\": \"cDNA cloning and sequencing, hydropathic analysis, sequence alignment, N-terminal amino acid sequencing\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct cDNA sequencing with structural domain identification, confirmed by protein N-terminal sequence\",\n      \"pmids\": [\"2753907\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"CPM is present at high concentrations in lung tissue (substantially higher than heart, liver, or kidney) and is localized by immunohistochemistry to alveolar type I pneumocytes and macrophages, but not type II alveolar epithelial cells. The enzyme is anchored to lung membranes via a phosphatidylinositol glycan (GPI) anchor, as demonstrated by release with bacterial phospholipase C. High CPM mRNA was confirmed by Northern blot in lung and placenta.\",\n      \"method\": \"Enzyme activity assay, immunoprecipitation, immunohistochemistry, phospholipase C treatment (GPI-anchor release), Northern blot\",\n      \"journal\": \"American journal of respiratory cell and molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (enzymatic activity, immunohistochemistry, phospholipase C cleavage) in multiple species\",\n      \"pmids\": [\"8338689\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"CPM was identified as the antigen recognized by monoclonal antibodies MAX.1 and MAX.11, which are almost undetectable on monocytes but highly expressed on differentiated macrophages. CPM expression and enzymatic activity markedly increase during in vitro monocyte-to-macrophage differentiation. Vitamin D3-induced monocytic differentiation of HL-60, U937, and THP-1 cell lines also upregulated CPM expression. Immunoaffinity purification with MAX.11 nearly completely depleted macrophage membrane preparations of CPM enzymatic activity, confirming identity.\",\n      \"method\": \"Immunoaffinity purification, N-terminal protein sequencing, enzymatic activity assay, mRNA quantification, antibody-mediated depletion, cell differentiation models\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal validation by enzymatic depletion and protein sequencing confirming antibody-antigen identity, replicated across multiple cell lines\",\n      \"pmids\": [\"7797563\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CPM expression is strongly induced during monocyte-to-macrophage differentiation in vitro and is expressed on macrophages in vivo during T-lymphocyte activation (e.g., allograft rejection, allergic alveolitis), suggesting CPM activity correlates with macrophage cytotoxic functions. Cloning of the murine CPM homologue revealed that mCPM is undetectable in murine primary macrophages and macrophage cell lines, indicating that CPM expression in macrophages is not conserved between human and mouse.\",\n      \"method\": \"mRNA expression analysis, immunohistochemistry of tissue sections, cDNA cloning (murine homologue), reverse transcription-PCR\",\n      \"journal\": \"Advances in experimental medicine and biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — expression and localization data with in vivo tissue analysis, but limited functional mechanistic follow-up\",\n      \"pmids\": [\"10849748\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"CPM mRNA and protein levels are significantly reduced in atrial tissue from patients with chronic persistent atrial fibrillation (CAF) compared to controls (CPM mRNA ~41 vs. ~86 arbitrary units; protein reduced to 47.5% of controls), suggesting that CPM-mediated bradykinin metabolism is altered during atrial fibrillation and may contribute to structural remodeling.\",\n      \"method\": \"Quantitative RT-PCR, protein expression analysis (Western/immunoblot), enzyme activity assay in human atrial tissue\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct human tissue analysis with multiple methods, but correlative with no loss-of-function manipulation\",\n      \"pmids\": [\"11444929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The 3.0 Å crystal structure of human GPI-free CPM was determined, revealing: (1) a 295-residue N-terminal catalytic domain similar to duck CPD-2; (2) an 86-residue β-sandwich C-terminal domain characteristic of the CPN/E family, more conically shaped than CPD-2; (3) a unique, partially disordered 25-residue C-terminal extension bearing the GPI-anchor attachment site. Modeling of Arg⁶-Met-enkephalin into the active site showed the S1' pocket is specifically shaped to accommodate P1'-Arg residues, explaining CPM's preference for cleaving C-terminal Arg over Lys.\",\n      \"method\": \"X-ray crystallography (3.0 Å), molecular modeling of substrate into active site\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure determination with substrate modeling providing mechanistic basis for substrate specificity\",\n      \"pmids\": [\"15066430\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"CPM is expressed by human bone marrow CD34⁺ hematopoietic stem/progenitor cells, myeloid/erythroid/megakaryocytic progenitors, mononuclear cells (MNC), polymorphonuclear cells (PMN), and stromal cells including mesenchymal stem cells. Recombinant CPM cleaves the C-terminal lysine of SDF-1α (1-68), yielding des-Lys SDF-1α (1-67). This CPM-mediated truncation reduces in vitro HSPC chemotaxis, an effect blocked by the carboxypeptidase inhibitor MMGPA. G-CSF significantly upregulates CPM expression in MNC and PMN, suggesting CPM participates in G-CSF-induced HSPC mobilization by attenuating the SDF-1α chemoattractant gradient.\",\n      \"method\": \"RT-PCR, Western blot, recombinant enzyme cleavage assay, HPLC/MS peptide analysis, in vitro chemotaxis assay, inhibitor rescue experiment, G-CSF stimulation of primary cells\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reconstituted enzymatic cleavage of SDF-1α confirmed biochemically, functional consequence demonstrated in chemotaxis assay with inhibitor validation\",\n      \"pmids\": [\"18292211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Somatic murine ACE (mACE) stably transfected in CHO or MDCK cells interacts with endogenous, co-localized GPI-anchored CPM, as demonstrated by co-immunoprecipitation and molecular/biochemical techniques. This interaction is independent of ACE's known dipeptidase activities. ACE proximity evokes release of CPM from the membrane, suggesting ACE has GPI-targeted properties and can act as a GPI-ase that releases GPI-anchored proteins such as CPM.\",\n      \"method\": \"Co-immunoprecipitation, stable transfection in CHO and MDCK cells, enzyme activity assays, cellular imaging\",\n      \"journal\": \"Biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP in cell-based system with functional readout (CPM release), single lab study\",\n      \"pmids\": [\"18844448\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CPM is highly expressed in embryonic liver progenitor cells (hepatoblasts) and is transiently induced during hepatic specification from human iPSCs. CPM⁺ cells isolated from differentiated hiPSCs at the immature hepatocyte stage proliferated extensively and expressed hepatoblast marker genes. These CPM⁺ cells differentiated into mature hepatocytes upon maturation induction and underwent cholangiocytic differentiation in 3D culture, demonstrating bi-potential progenitor capacity. Thus, CPM surface expression identifies and allows isolation of hiPSC-derived bi-potential liver progenitor cells.\",\n      \"method\": \"Flow cytometry cell sorting, colony formation/proliferation assays, gene expression profiling, hepatic maturation induction, 3D cholangiocytic differentiation culture, immunostaining\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — prospective isolation using CPM as surface marker with functional bi-potential differentiation validated by multiple orthogonal methods\",\n      \"pmids\": [\"26365514\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CPM was identified as a direct target of miR-146a-5p in colorectal cancer cells. CPM expression inhibits migration and invasion of CRC cells. Both miR-146a-5p overexpression and CPM knockdown regulated Src and FAK phosphorylation/expression, placing CPM upstream of the Src-FAK signaling pathway. Restoration of CPM blocked miR-146a-5p-induced migration, establishing a functional miR-146a-5p/CPM/Src-FAK axis in CRC cell motility.\",\n      \"method\": \"Luciferase reporter assay (direct target validation), siRNA/overexpression cell migration and invasion assays, Western blot for Src/FAK pathway components, rescue experiments\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — direct target validation by luciferase assay, epistasis by rescue experiment, single lab study\",\n      \"pmids\": [\"28186967\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A functional SNP in the CPM gene promoter region (rs12812500 G allele) is significantly associated with increased silicosis susceptibility. Luciferase reporter gene assays demonstrated that the mutant G allele drives significantly higher CPM promoter activity than the wild-type C allele, indicating the variant increases CPM transcription and may contribute to silicosis susceptibility through elevated CPM expression in lung tissue.\",\n      \"method\": \"Case-control association study, luciferase reporter gene assay with promoter variants, mRNA expression in peripheral blood leukocytes\",\n      \"journal\": \"Occupational and environmental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — luciferase reporter assay provides direct functional evidence for SNP effect on promoter activity, supported by expression data\",\n      \"pmids\": [\"30674606\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"CPM was identified as a GPI-anchored protein in a human lipid raft-enriched membrane fraction by a mass spectrometry-based proteomics strategy, confirming its GPI-anchored membrane localization in intact cells.\",\n      \"method\": \"Biochemical enrichment of lipid raft fractions, mass spectrometry proteomics, computational GPI-anchor sequence analysis\",\n      \"journal\": \"Molecular & cellular proteomics : MCP\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — experimental confirmation of GPI-anchor localization by lipid-raft proteomics and MS, consistent with prior biochemical data\",\n      \"pmids\": [\"14517339\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CPM was identified among 11 human GPI-anchored proteins released from plasma membrane fractions by phospholipase D (PLD) treatment, further confirming its GPI-anchor membrane attachment. Unlike phospholipase C, PLD is not affected by GPI structural heterogeneity, validating CPM's GPI-AP status across different structural GPI variants.\",\n      \"method\": \"Phospholipase D treatment of human plasma membrane fractions, capillary LC-MS/MS proteomics\",\n      \"journal\": \"Journal of proteome research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — enzymatic release and MS identification provide direct experimental confirmation of GPI anchoring\",\n      \"pmids\": [\"16602701\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Carboxypeptidase M (CPM) is a GPI-anchored, zinc-dependent metallocarboxypeptidase on the extracellular plasma membrane surface that cleaves C-terminal basic residues (Arg > Lys) from peptide hormones and growth factors including bradykinin, enkephalins, and SDF-1α, thereby modulating their biological activity; its crystal structure reveals a CPN/E-subfamily catalytic domain with an S1' pocket preferentially accommodating Arg, it is strongly induced during monocyte-to-macrophage differentiation and in embryonic hepatoblasts/hiPSC-derived liver progenitors, it interacts with and is released by ACE in a GPI-ase-dependent manner, and in colorectal cancer cells it suppresses migration by acting upstream of the Src-FAK signaling pathway.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"Carboxypeptidase M (CPM) is a GPI-anchored membrane-bound ectopeptidase that cleaves C-terminal basic amino acids from immunologically important peptides including bradykinin, anaphylatoxins, and enkephalins [PMID:10849748]. CPM expression is induced during monocyte-to-macrophage maturation, correlating with macrophage cytotoxic function, and it also marks hepatoblasts and liver progenitor cells during embryonic development, where CPM+ cells exhibit bi-potential progenitor characteristics capable of differentiating into both hepatocytes and cholangiocytes [PMID:10849748, PMID:26365514]. At the cell surface, CPM physically interacts with angiotensin-converting enzyme (ACE), and this interaction—independent of ACE catalytic activity—promotes ACE-evoked release of CPM from the membrane [PMID:18844448].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Establishing CPM as a GPI-anchored macrophage ectopeptidase resolved the identity of a membrane enzyme responsible for processing bradykinin, anaphylatoxins, and enkephalins and linked its induction to monocyte-to-macrophage differentiation.\",\n      \"evidence\": \"Antibody-based identification, substrate cleavage assays, in vitro maturation assays, and cDNA cloning of the murine homologue\",\n      \"pmids\": [\"10849748\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Substrate specificity beyond bradykinin/anaphylatoxins/enkephalins was not fully explored\",\n        \"Mechanism of transcriptional induction during macrophage maturation was not defined\",\n        \"In vivo functional consequences of CPM activity on macrophage cytotoxicity were not tested\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstrating a physical interaction between ACE and CPM at the cell membrane revealed that ACE can evoke release of the GPI-anchored CPM independent of its own dipeptidase activity, suggesting a non-enzymatic signaling or structural role for ACE in CPM shedding.\",\n      \"evidence\": \"Stable co-transfection of ACE and CPM in CHO/MDCK cells, co-localization studies, and functional release assays\",\n      \"pmids\": [\"18844448\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"The molecular determinants mediating the ACE–CPM interaction were not mapped\",\n        \"Whether endogenous ACE–CPM interaction occurs on macrophages or other cell types in vivo was not shown\",\n        \"Mechanism by which ACE triggers GPI-anchor cleavage or CPM release was not identified\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identifying CPM as a surface marker of hepatoblasts and iPSC-derived hepatic progenitors established a developmental role beyond immune function, enabling prospective isolation of bi-potential liver progenitor cells.\",\n      \"evidence\": \"Cell surface marker-based isolation from differentiated hiPSCs, three-dimensional culture for cholangiocytic differentiation, and gene expression profiling\",\n      \"pmids\": [\"26365514\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether CPM enzymatic activity is functionally required for hepatic progenitor specification or simply marks these cells was not determined\",\n        \"In vivo transplantation and engraftment of CPM+ progenitors was not fully validated\",\n        \"Upstream signals driving CPM induction during hepatic specification were not identified\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identification of a functional promoter variant (rs12812500) that increases CPM transcriptional activity provided the first evidence that CPM expression levels are genetically regulated and can be linked to disease-associated expression differences.\",\n      \"evidence\": \"Luciferase reporter assay comparing alleles and case-control mRNA expression analysis in peripheral blood leucocytes\",\n      \"pmids\": [\"30674606\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"Reporter assay lacked mutagenesis validation or protein-level functional follow-up\",\n        \"The transcription factor(s) binding differentially to the variant allele were not identified\",\n        \"Association was observed in a single cohort without independent replication\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The in vivo physiological substrates of CPM in specific tissue contexts (immune, hepatic) and whether its enzymatic activity—versus its role as a surface marker—is essential for progenitor specification and macrophage function remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No genetic loss-of-function studies (knockout or catalytic-dead mutant) have been reported\",\n        \"Structural basis of the ACE–CPM interaction is unknown\",\n        \"Comprehensive substrate profiling in physiologically relevant contexts has not been performed\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0168256\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"ACE\"],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"Carboxypeptidase M (CPM) is a GPI-anchored, zinc-dependent metallocarboxypeptidase that resides on the extracellular face of the plasma membrane and cleaves C-terminal basic residues (Arg > Lys) from peptide substrates including bradykinin, enkephalins, and SDF-1α, thereby modulating peptide hormone signaling and chemotactic gradients [PMID:2914904, PMID:18292211]. Its crystal structure reveals a CPN/E-subfamily catalytic domain with an S1' pocket that preferentially accommodates arginine, explaining the Arg-over-Lys selectivity [PMID:15066430]. CPM is strongly induced during monocyte-to-macrophage differentiation and serves as a surface marker of bipotential hepatic progenitor cells derived from human iPSCs [PMID:7797563, PMID:26365514]. In colorectal cancer cells, CPM suppresses migration by acting upstream of the Src–FAK signaling pathway [PMID:28186967].\",\n  \"teleology\": [\n    {\n      \"year\": 1989,\n      \"claim\": \"Biochemical purification and cDNA cloning established CPM as a novel membrane-bound zinc metallocarboxypeptidase distinct from all previously known carboxypeptidases, with full kinetic parameters for bradykinin and enkephalin substrates and a predicted GPI-anchor signal in its primary sequence.\",\n      \"evidence\": \"Affinity purification from human placental microvilli with in vitro kinetics; cDNA cloning and sequence analysis\",\n      \"pmids\": [\"2914904\", \"2753907\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"GPI anchoring predicted from sequence but not yet experimentally verified\",\n        \"No structural basis for substrate specificity\",\n        \"In vivo physiological substrates and tissue distribution not yet established\"\n      ]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Experimental confirmation that CPM is GPI-anchored and identification of lung as the tissue with highest expression resolved the membrane attachment mechanism and pointed to respiratory and inflammatory biology as key contexts.\",\n      \"evidence\": \"Phospholipase C release from lung membranes, immunohistochemistry localizing CPM to alveolar type I pneumocytes and macrophages, Northern blot\",\n      \"pmids\": [\"8338689\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Functional role of CPM in alveolar biology not tested\",\n        \"No lipid-raft or microdomain localization data yet\"\n      ]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Identification of CPM as the MAX.1/MAX.11 macrophage differentiation antigen established that CPM expression is strongly induced during monocyte-to-macrophage differentiation, linking the enzyme to innate immune cell maturation.\",\n      \"evidence\": \"Immunoaffinity purification, N-terminal sequencing, enzymatic activity depletion, monocyte differentiation in vitro and in HL-60/U937/THP-1 cell lines\",\n      \"pmids\": [\"7797563\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which CPM is transcriptionally upregulated during differentiation unknown\",\n        \"Functional consequence of CPM activity on macrophage effector functions not tested\"\n      ]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Proteomic and enzymatic approaches confirmed CPM resides in lipid-raft membrane domains via GPI anchoring, extending the biochemical verification across orthogonal methods and GPI structural variants.\",\n      \"evidence\": \"Lipid raft proteomics (MS) and phospholipase D release from plasma membrane fractions with LC-MS/MS\",\n      \"pmids\": [\"14517339\", \"16602701\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether raft localization influences substrate access or enzymatic activity not examined\",\n        \"Dynamics of GPI-anchor remodeling in vivo unknown\"\n      ]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"The crystal structure of CPM at 3.0 Å resolution explained the enzyme's Arg-over-Lys specificity by revealing a CPN/E-family catalytic domain with an S1' pocket shaped to accommodate arginine, providing the first structural framework for understanding substrate selectivity.\",\n      \"evidence\": \"X-ray crystallography at 3.0 Å with molecular modeling of Arg⁶-Met-enkephalin into the active site\",\n      \"pmids\": [\"15066430\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No co-crystal with bound substrate or transition-state analog\",\n        \"Structural basis for GPI-anchor attachment region disordered and unresolved\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"CPM was shown to cleave SDF-1α and attenuate hematopoietic stem/progenitor cell chemotaxis, establishing a physiological substrate beyond bradykinin/enkephalins and implicating CPM in G-CSF-induced stem cell mobilization; separately, ACE was found to physically interact with and release GPI-anchored CPM from the membrane.\",\n      \"evidence\": \"Recombinant CPM cleavage of SDF-1α confirmed by HPLC/MS, chemotaxis assay with inhibitor rescue; Co-IP of ACE and CPM in transfected CHO/MDCK cells\",\n      \"pmids\": [\"18292211\", \"18844448\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"In vivo validation of CPM-SDF-1α axis in stem cell mobilization not performed\",\n        \"ACE–CPM interaction demonstrated in overexpression system; endogenous reciprocal validation lacking\",\n        \"Mechanism of ACE-mediated GPI-ase activity not defined\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"CPM surface expression was shown to mark bipotential liver progenitor cells (hepatoblasts) during human iPSC-to-hepatocyte differentiation, enabling prospective isolation of cells capable of both hepatocyte and cholangiocyte maturation.\",\n      \"evidence\": \"FACS sorting of CPM⁺ cells from differentiated hiPSCs, colony formation, hepatic maturation, and 3D cholangiocytic differentiation\",\n      \"pmids\": [\"26365514\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether CPM enzymatic activity is functionally required for hepatic progenitor specification is unknown\",\n        \"Transcriptional regulation of CPM induction during hepatic specification not dissected\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"In colorectal cancer cells, CPM was identified as a direct miR-146a-5p target that suppresses migration by acting upstream of Src–FAK signaling, extending CPM's biological roles beyond peptide metabolism to tumor cell motility.\",\n      \"evidence\": \"Luciferase reporter target validation, siRNA knockdown and overexpression migration/invasion assays, Western blot for Src/FAK, rescue experiments in CRC cell lines\",\n      \"pmids\": [\"28186967\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether the anti-migratory effect requires CPM catalytic activity or a non-enzymatic mechanism is untested\",\n        \"The specific CPM substrate(s) relevant to Src–FAK regulation are unidentified\",\n        \"Single-lab finding without in vivo tumor model validation\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"A promoter SNP (rs12812500) was functionally linked to increased CPM transcription and silicosis susceptibility, connecting CPM expression levels in lung to occupational lung disease risk.\",\n      \"evidence\": \"Case-control genetic association study with functional luciferase reporter assay for allele-specific promoter activity\",\n      \"pmids\": [\"30674606\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism by which elevated CPM expression promotes silicosis pathology not defined\",\n        \"Replication in independent cohorts not reported\",\n        \"No loss-of-function or animal model validation\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include whether CPM catalytic activity is required for its roles in macrophage function and tumor suppression, what the full in vivo substrate repertoire is, and how CPM expression is transcriptionally regulated during differentiation and disease.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No catalytically dead knock-in study to separate enzymatic from non-enzymatic roles\",\n        \"No in vivo knockout phenotype reported\",\n        \"No substrate co-crystal structure available\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 6, 7]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 6, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1, 2, 12, 13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3, 4, 7]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [7, 10]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 6, 7]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"ACE\",\n      \"SDF1\",\n      \"SRC\",\n      \"FAK\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}